Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
During glaucoma surgery, a new opening is created that allows fluid to drain out of the eye,
bypassing the clogged drainage channels that are malfunctioning in patients with glaucoma. In
some patients who have had glaucoma surgery too much fluid flows out and this results in a
pressure that is too low. This may cause swelling of one layer at the back of the eye called
the choroid. The formation of this swelling, called a choroidal effusion or "choroidal",
often makes the eye pressure stay too low, and one of the results is a decrease in vision.
The treatment for a choroidal effusion is to try to raise the eye pressure somewhat to allow
the swelling to subside. In our clinical work, we have found that an injection with an
anti-inflammatory drug called triamcinolone appears to be helpful in speeding up healing. We
plan to compare two groups of patients with choroidal effusions, one group that gets an
injection of triamcinolone and one that gets a "sham" treatment with nothing injected and
compare the length of time it takes the choroidal effusions to disappear. Both groups receive
the standard treatment with eye drops. We will also assess the outcome of the glaucoma
surgery and any other complications that may occur. This research is aimed at studying a new
method of improving the outcomes of surgery for glaucoma patients, and further the treatment
of glaucoma.